Workskop on Cellular and Oligonucleotide therapies
On October 17th, RGCC founder and genetics pioneer Dr Ioannis Papasotiriou and members of RGCC’s scientific team hosted a workshop regarding Cellular and Oligonucleotide therapies.
On October 17th, RGCC founder and genetics pioneer Dr Ioannis Papasotiriou and members of RGCC’s scientific team hosted a workshop regarding Cellular and Oligonucleotide therapies.
On October 14th, RGCC’s director and members of his team, hosted an online-webinar about RGCC’s tests, and therapies. Participants had also the opportunity to watch real-time, the administration of therapies on an experimental model.
On September 19th, 2020, we welcomed clinicians from the wider area. Dr. Papasotiriou and the members of the Research and Development Department presented the workflow they follow, including Cells Isolation, Targets Identification and Validation, Small Molecular Weight molecules production, Monoclonal Antibodies production as well as Pharmaceutical formulation of all products. At the final part, clinicians […]
Integrative Oncology | RGCC founder and genetics pioneer Dr Ioannis Papasotiriou hosted a two-day symposium in Melbourne, Australia. Take a look at the range of subjects we covered at the gathering and hear from some of the delegates who took part.
On January 2020 took place the in Tokyo the Clinical CTC Seminar. This event was promoted by Dr. Atsushi Yanagisawa, Chairman of the Intravenous Therapy Study Group and Dr. Kunihiro Kitamura, Director of the Kitamura Clinic in Fukuoka. Dr. Ioannis Papasotiriou was one of the basics lecturer.
RGCC’s Workshop, November 2019 – Germany, Halle
CIMI -International Congress of Integrative Medicine -Understanding Patient Individuality and Building a Therapeutic Path, November 2019 – Brazil, Uberlandia
RGCC Group Meet Clinical Training, October 2019 – USA, Dallas
IX. Hyperthermie Kongress- Hyperthermie als Baustein der Immunologie, September 2019 – Germany, Berlin
RGCC in Thessaloniki International Exhibition, September 2019
RGCC staff, collaborators and branch officers will meet in Unterageri, near Zug, Switzerland to network, discuss new treatment protocols and hear about RGCC’s latest work.